Abstract:Traditional Chinese medicines (TCMs) have continued to be a treasure trove. The study of chemodiversity and versatility of bioactivities has always been an important content of pharmacophylogeny. There is amazing progress in the discovery and research of natural components with novel structures and significant bioactivities in 2020. In this paper we review 271 valuable natural products, including terpenoids, steroids, flavonoids, phenylpropanoids, phenolics, nitrogen containing compounds and essential oil, etc., isolated and identified from TCMs published in journals of Chinese Traditional and Herbal Drugs (Zhong Cao Yao) and Chinese Herbal Medicines (CHMs), and focus on their structures, source organisms, and relevant bioactivities, paying special attention to structural characteristics of novel compounds and newly revealed pharmacological properties of known compounds. It is worth noting that natural products with antitumor activity still constitute the primary object of research. Among the reported compounds, two new triterpenoids, i.e., ursolic acid 3-O-β-cis-caffeate and mollugoside E, display remarkable cytotoxicity against PC-9 and HL-60 cell lines, respectively. Three known phenolic compounds, i.e., pyoluteorin, 4-hydroxy-3-methoxy cinnamaldehyde and 3,7-dimethoxy-5-hydroxy-1,4-phenanthrenequinone, exhibit significant cytotoxicity against multiple cell lines. Numerous studies on the free radical scavenging activity of reported compounds are currently underway. In vitro, three known phenolic compounds, i.e., 3,4-O-dicaffeoylquinic acid methyl ester, 3,4,5-O-tricaffeoylquinic acid methyl ester and arbutin, had more considerable antioxidant activities than vitamin C. The anti-inflammatory, anti-diabetic, hypolipidemic, neuroprotective and antimicrobial activities of isolated compounds are also encouraging. The structural characteristics and bioactivities of TCM compounds highlighted here reflect the enormous progress of CHM research in 2020 and will play a positive role in the future drug discovery and development. According to pharmacophylogeny, the phylogenetic distribution of compounds with different natures and flavors can be explored, with view to better mining TCM resources.

Research Progress in Ellagitannin Compounds

Research progress of ellagitannin intestinal metabolite urolithins

Research progress in Galla chinensis and gallic tannins

Recent Advances in Anticancer Activities and Drug Delivery Systems of Tannins

Health functions and related molecular mechanisms of ellagitannin-derived urolithins

Streamlined Synthesis of Ellagitannins: Site-Selective Functionalization of the Glucose Core and Stereodivergent Construction of the Hexahydroxydiphenoic Groups

Research Progress on the Anticarcinogenic Mechanisms of Ellagic Acid

Research Progress on Tannins

Research Progress and Application of Plant Proanthocyanidin

Biodegradation of gallotannins and ellagitannins.

Ellagitannins and Oligomeric Proanthocyanidins of Three Polygonaceous Plants

Anti-complement epimeric ellagitannins from Juglans mandshurica

Chemical and Biological Significance of Oenothein B and Related Ellagitannin Oligomers with Macrocyclic Structure

Research Progress of FructusToosendan

Research and Development of Natural Product Tanshinone I: Pharmacology, Total Synthesis, and Structure Modifications

Research Progress on Anti-Tumor Mechanism of Tannins in Traditional Chinese Medicine

Research progress of Chinese herbal medicine compounds and their bioactivities: Fruitful 2020

Ellagitannins from Eucalyptus camaldulensis and their potential use in the food industry

Research Progress of Tanshinones

Research progress of Gastrodia elata Blume polysaccharides: a review of chemical structures and biological activities

Research progress in Gallic acid from Galla Chinensis